about
Lipidomics-Reshaping the Analysis and Perception of Type 2 DiabetesFirst-in-class cardiolipin-protective compound as a therapeutic agent to restore mitochondrial bioenergeticsComparative plasma lipidome between human and cynomolgus monkey: are plasma polar lipids good biomarkers for diabetic monkeys?Lipidomics for studying metabolismA hyphenated microLC-Q-TOF-MS platform for exosomal lipidomics investigations: application to RCC urinary exosomes.Localization of fatty acyl and double bond positions in phosphatidylcholines using a dual stage CID fragmentation coupled with ion mobility mass spectrometry.Shotgun lipidomics on high resolution mass spectrometers.Aliphatic chain length by isotropic mixing (ALCHIM): determining composition of complex lipid samples by ¹H NMR spectroscopyA reversed-phase capillary ultra-performance liquid chromatography-mass spectrometry (UPLC-MS) method for comprehensive top-down/bottom-up lipid profilingEvaluation of Collision Cross Section Calibrants for Structural Analysis of Lipids by Traveling Wave Ion Mobility-Mass Spectrometry.Analysis of Retina and Erythrocyte Glycerophospholipid Alterations in a Rat Model of Type 1 Diabetes.Plasma lipidome is independently associated with variability in metabolic syndrome in Mexican American families.Multidimensional approaches in LC and MS for phospholipid bioanalysis.Lipidomics in the Study of Hypertension in Metabolic Syndrome.Changes of the plasma metabolome during an oral glucose tolerance test: is there more than glucose to look at?Assessment of altered lipid homeostasis by HILIC-ion mobility-mass spectrometry-based lipidomics.
P2860
Q28073169-508E12D4-FCF7-4FBB-B09F-D43C0C3589A0Q28383451-81AC9C25-5103-4690-8AE2-EA02265E75DFQ28478051-36D7B1D9-D99F-4BB5-AC62-6F81552B30CBQ28802472-479CD8EB-7B9F-4EBA-941E-C035999428A9Q34208607-B8D0B122-816C-4649-92D6-445AF227243CQ35172824-EB57A8E5-41DC-455D-8C59-342DE0BC7F3BQ35234627-3137DB98-A1CB-4E25-A3A6-D9F30AF0966BQ35778654-6DDA39C0-1010-44D0-9C5E-1CFBA544F841Q36492220-3C582F8B-6581-420F-9057-AC5C7FC28A5BQ37113867-B2D33B72-8886-4FAD-A807-EE80AB60B0F8Q37450074-94CC0F22-235C-4BC3-B44E-9DEF1F21B29AQ37716371-F9DFECE1-B92C-4C89-8ABC-6FB8BA318D3BQ37810217-F6392786-0690-4492-99F2-6679B7AF5C65Q39123802-1A3B3A0E-A069-4613-A600-5EC6DAA92D21Q46208508-E8E574BA-2052-4B86-9960-0B2025576D14Q54877734-58CD92C7-A65F-4DDE-AD60-B7F42EE0A36E
P2860
description
2007 nî lūn-bûn
@nan
2007 թուականին հրատարակուած գիտական յօդուած
@hyw
2007 թվականին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Lipidomics in diabetes and the metabolic syndrome
@ast
Lipidomics in diabetes and the metabolic syndrome
@en
Lipidomics in diabetes and the metabolic syndrome
@nl
type
label
Lipidomics in diabetes and the metabolic syndrome
@ast
Lipidomics in diabetes and the metabolic syndrome
@en
Lipidomics in diabetes and the metabolic syndrome
@nl
prefLabel
Lipidomics in diabetes and the metabolic syndrome
@ast
Lipidomics in diabetes and the metabolic syndrome
@en
Lipidomics in diabetes and the metabolic syndrome
@nl
P1476
Lipidomics in diabetes and the metabolic syndrome
@en
P2093
Richard W Gross
Xianlin Han
P356
10.1016/S0076-6879(07)33004-8
P407
P577
2007-01-01T00:00:00Z